Cross-border entry in biologicals and plant nutrition
Country, crop and partner prioritisation for a European group entering Latin America with phased investment.
Case examples
Three cross-border cases inside agribusiness.
Representative, anonymised and realistic examples of how Dextra structures complex decisions across Strategic Consulting, Regulatory Affairs and M&A.
StrategyRegional entry in biologicals and plant nutrition
RegulatoryLATAM crop protection registration programme
M&AScreening and diligence of a distribution platform
Selected examples
Each case follows the same logic: problem or opportunity, process, actions and result.
Regional registration programme across LATAM
Sequencing and local execution of registrations for a European crop protection company with a multi-country technical portfolio.
Commercial diligence of a distribution platform
Assessment of revenue quality, registrations, channel and integration risk before a cross-border offer decision.
Problem / opportunity
The client saw rising demand in intensive crops, but lacked clarity on which countries to prioritise, which products to adapt and which local partner model could support technical and commercial growth.
Process
Dextra compared countries by crop area, pest pressure, adoption of biologicals, channel structure, regulatory requirements, competitive intensity and margin capture potential.
Actions
We designed a country-crop sequence, distributor archetypes, technical value proposition by segment, initial pricing, channel messages and investment gates.
Result
The client prioritised three markets, opened conversations with strategic partners and approved phased entry with commercial and regulatory milestones before scaling investment.
Problem / opportunity
The client had molecules with regional potential, but dossiers, internal resources and commercial priorities were not aligned by country, crop and registration window.
Process
Dextra reviewed dossiers, data ownership, technical gaps, local requirements, authority timelines, equivalence options, possible claims and expected commercial value by market.
Actions
Molecules, formulations and countries were prioritised, a local specialist network was coordinated, a dossier dashboard was created and responses to authority risks were defined.
Result
The programme was sequenced by value and feasibility, with lower rework risk, management visibility on critical milestones and a clear route for commercial and regulatory teams.
Problem / opportunity
A North American industrial buyer needed to know whether historical growth was defensible, how much value depended on owned registrations, what channel risks existed and which synergies were realistic.
Process
Dextra analysed sales by country and crop, customer concentration, margin by product family, registration quality, supplier dependency, team robustness and integration risks.
Actions
Growth scenarios, red flags, management diligence questions, financial model adjustments and negotiation conditions were built before the offer decision.
Result
The buyer made a risk-adjusted offer decision, with post-deal priorities, signing conditions and a clear agenda for value capture after acquisition.
Common thread
The value is in connecting evidence to action.
01Strategic clarity
Which markets, assets, products or partners deserve priority.
02Regulatory realism
What can be registered, when, with which dossier and under which country constraints.
03Transaction confidence
What the asset is worth, who it fits, what diligence must prove and how value can be captured.
04Execution path
What the client should do next, in what order and with which supporting evidence.
Next step
Bring Dextra a decision that matters.
Start with the issue, not the deliverable.
Share the product area, geography, portfolio issue, registration programme or transaction context. Dextra will help shape the evidence path and next step.
Talk to Dextra